NYU Langone Medical Center

Download NYU Langone Medical Center

Post on 12-Nov-2014

299 views

Category:

Health & Medicine

1 download

Embed Size (px)

DESCRIPTION

NYU Langone Medical Center*References*Blackburn G. Effect of degree of weight loss on health benefit...

TRANSCRIPT

  • 1. NYU Langone Medical Center NYU Langone Medical Center * References *Blackburn G. Effect of degree of weight loss on health benefits.Obes Res.1995;3(suppl 2):211S216S. *Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II.Ann Intern Med.2001;134:1-11. *Felson DT, Zhang Y, Anthony JM, et al. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study.Ann Intern Med.1992;116:535-539. *Goldstein DJ. Beneficial health effects of modest weight loss.Int J Obes.1992;16:397-415. *Solomon CG, Manson JE. Obesity and mortality: a review of the epidemiologic data.Am J Clin Nutr.1997;66(suppl 4):1044S-1050S. *Moore LL, Visioni AJ, Wilson PW, et al. Can sustained weight loss in overweight individuals reduce the risk of diabetes mellitus?Epidemiology.2000;11:269-273. *Kaats GR, Blum K, Fisher JA, et al. Effects of chromium picolinate supplementation on body composition: a randomized, double-masked, placebo-controlled study.Curr Ther Res.1996;57:747765. *Kaats GR, Blum K, Pullin D, et al. A randomized, double-masked, placebo-controlled study of the effects of chromium picolinate supplementation on body composition: a replication and extension of a previous study.Curr Ther Res.1998;59:379-388. *Grant KE, Chandler RM, Castle AL, et al. Chromium and exercise training: Effect on obese women.Med Sci Sports Exerc.1997;29:992-998. *Trent LK, Thieding-Cancel D. Effects of chromium picolinate on body composition.J Sports Med Phys Fitness.1995;35:273-280. *Clancy SP, Clarkson PM, DeCheke ME, et al. Effects of chromium picolinate supplementation on body composition, strength, and urinary chromium loss in football players.Int J Sport Nutr.1994;4:142-153. *Hallmark MA, Reynolds TH, DeSouza CA, et al. Effects of chromium and resistive training on muscle strength and body composition.Med Sci Sports Exerc.1996;28:139-144. *Amato P, Morales AJ, Yen SS. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women.J Gerontol A Biol Sci Med Sci.2000;55:M260-M263. *Lukaski HC, Bolonchuk WW, Siders WA, et al. Chromium supplementation and resistance training:
  • 2. effects on body composition, strength, and trace element status of men.Am J Clin Nutr.1996;63:954964. *Stanko RT, Reynolds HR, Hoyson R, et al. Pyruvate supplementation of a low-cholesterol, low-fat diet: effects on plasma lipid concentrations and body composition in hyperlipidemic patients.Am J Clin Nutr.1994;59:423-427. *Stanko RT, Tietze DL, Arch JE. Body composition, energy utilization, and nitrogen metabolism with a 4.25-MJ/d low-energy diet supplemented with pyruvate.Am J Clin Nutr.1992;56:630-635. *Stanko RT, Arch JE. Inhibition of regain in body weight and fat with addition of 3-carbon compounds to the diet with hyperenergetic refeeding after weight reduction.Int J Obes Relat Metab Disord.1996;20:925-930. *Stanko RT, Tietze DL, Arch JE. Body composition, energy utilization, and nitrogen metabolism with a severely restricted diet supplemented with dihydroxyacetone and pyruvate.Am J Clin Nutr.1992;55:771-772. *Kalman D, Colker CM, Wilets I, et al. The effects of pyruvate supplementation on body composition in overweight individuals.Nutrition.1999;15:337-340. *Ryttig KR, Tellnes G, Haegh L, et al. A dietary fibre supplement and weight maintenance after weight reduction: a randomized, double-blind, placebo-controlled long-term trial.Int J Obes.1989;13:165-171. *Rigaud D, Ryttig KR, Angel LA, et al. Overweight treated with energy restriction and a dietary fibre supplement: a 6-month randomized, double-blind, placebo-controlled trial.Int J Obes.1990;14:763769. *Rossner S, von Zweigbergk D, Ohlin A, et al. Weight reduction with dietary fibre supplements. Results of two double-blind randomized studies.Acta Med Scand.1987;222:83-88. *Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study.Int J Obes.1984;8:289-293. *Reffo GC, Ghirardi PE, Forattani C. Double-blind evaluation of glucomannan versus placebo in postinfarcted patients after cardiac rehabilitation.Curr Ther Res.1990;47:753-758. *Vido L, Facchin P, Antonello I, et al. Childhood obesity treatment: double blinded trial on dietary fibres (glucomannan) versus placebo.Paediatr Paedol.1993;28:133-136. *Schiller RN, Barrager E, Schauss AG, et al. A randomized, double-blind, placebo-controlled study examining the effects of a rapidly soluble chitosan dietary supplement on weight loss and body composition in overweight and mildly obese individuals.J Am Nutraceutical Assoc.2001;4:42-49. *Pittler MH, Abbot NC, Harkness EF, et al. Randomized, double-blind trial of chitosan for body weight reduction.Eur J Clin Nutr.1999;53:379-381. *Di Lorenzo C, Williams CM, Hajnal F, et al. Pectin delays gastric emptying and increases satiety in obese subjects.Gastroenterology.1988;95:1211-1215.
  • 3. *Wilmshurst P, Crawley JC. The measurement of gastric transit time in obese subjects using 24Na and the effects of energy content and guar gum on gastric emptying and satiety.Br J Nutr.1980;44:16. *Heini AF, Lara-Castro C, Schneider H, et al. Effect of hydrolyzed guar fiber on fasting and postprandial satiety and satiety hormones: a double-blind, placebo-controlled trial during controlled weight loss.Int J Obes.1998;22:906-909. *Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study.Int J Obes.1984;8:289-293. *Reffo GC, Ghirardi PE, Forattani C. Double-blind evaluation of glucomannan versus placebo in postinfarcted patients after cardiac rehabilitation.Curr Res Ther.1990;47:753-758. *Vuksan V, Jenkins DJ, Spadafora P, et al. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.Diabetes Care.1999;22:913-919. *Ryttig KR, Tellnes G, Haegh L, et al. A dietary fibre supplement and weight maintenance after weight reduction: a randomized, double-blind, placebo-controlled long-term trial.Int J Obes.1989;13:165-171. *Rossner S, von Zweigbergk D, Ohlin A, et al. Weight reduction with dietary fibre supplements. Results of two double-blind randomized studies.Acta Med Scand.1987;222:83-88. *Byerley WF, Judd LL, Reimherr FW, et al. 5-hydroxytryptophan: a review of its antidepressant efficacy and adverse effects.J Clin Psychopharmacol.1987;7:127-137. *Poldinger W, Calanchini B, Schwarz W. A functional-dimensional approach to depression: Serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine.Psychopathology.1991;24:53-81. *Ceci F, Cangiano C, Cairella M, et al. The effects of 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects.J Neural Transm.1989;76:109-117. *Cangiano C, Ceci F, Cascino A, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan.Am J Clin Nutr.1992;56:863-867. *Cangiano C, Ceci F, Cairella M, et al. Effects of 5-Hydroxytryptophan on eating behavior and adherence to dietary prescriptions in obese adult subjects.Adv Exp Med Biol.1991;294:591-593. *Cangiano C, Laviano A, Del Ben M, et al. Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients.Int J Obes Relat Metab Disord.1998;22:648-654. *Chao D, Espeland MA, Farmer D, et al. Effect of voluntary weight loss on bone mineral density in older overweight women.J Am Geriatr Soc.2000;48:753-759. *Davies KM, Heaney RP, Recker RR, et al. Calcium intake and body weight.J Clin Endocrinol Metab.2000;85:4635-4638.
  • 4. *Greenwood MRC, Cleary MP, Gruen R, et al. Effect of hydroxycitrate on development of obesity in the Zucker obese rat.Am J Physiol.1981;240:E72-E78. *Sullivan AC, Triscari J. Metabolic regulation as a control for lipid disorders. Influence ofhydroxycitrate on experimentally induced obesity in the rodent.Am J Clin Nutr.1977;30:767-776. *Sullivan AC, Triscari J, Hamilton JG, et al. Effect ofhydroxycitrate upon the accumulation of lipid in the rat: I. Lipogenesis.Lipids.1974;9:121-128. *Sullivan AC, Triscari J, Hamilton JG, et al. Effect ofhydroxycitrate upon the accumulation of lipid in the rat. II. Appetite.Lipids.1974;9:129-134. *Sergio W. A natural food, malabar tamarind, may be effective in the treatment of obesity.Med Hypotheses.1988;27:39-40. *Lowenstein JM. Effect of hydroxycitrate on fatty acid synthesis by rat liver in vivo.J Biol Chem.1971;246:629-632. *Triscari J, Sullivan AC. Comparative effects of hydroxycitrate and (+)-allo-hydroxycitrate on acetyl CoA carboxylase and fatty acid and cholesterol synthesis in vivo.Lipids.1977;12:357-363. *Cheema-Dhadli S, Harlperin ML, Leznoff CC. Inhibition of enzymes which interact with citrate by hydroxycitrate and 1,2,3,-tricarboxybenzene.Eur J Biochem.1973;38:98-102. *Sullivan AC, Hamilton JG, Miller ON, et al. Inhibition of lipogenesis in rat liver byhydroxycitrate.Arch Biochem Biophys.1972;150:183-190. *Heymsfield SB, Allison DB, Vasselli JR, et al. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial.JAMA.1998;280:1596-1600. *Kriketos AD, Thompson HR, Greene H, et al. Hydroxycitric acid does not affect energy expenditure and substrate oxidation in adult males in a post-absorptive state.Int J Obes Relat Metab Disord.1999;23:867-873. *Mattes RD, Bormann L. Effects of hydroxycitric acid on appetitive variables.Physiol Behav.2000;71:87-94. *Astrup A, Breum L, Toubro S, et al. The effect a

Recommended

View more >